Background: Acute lung injury (ALI) is a pulmonary disorder that leads to acute failure of respiration and thereby results in a high mortality worldwide. Increasing studies have verified that TLR4 is a promoter in ALI, however, the underlying upstream mechanisms of TLR4 was still rarely investigated. Methods: Lipopolysaccharide (LPS) was used to induce cell model and animal model. A wide range of experiments including RT-qPCR, Western blot, ELISA, flow cytometry, H&E staining, RIP, luciferase activity and caspase-3 activity were carried out to figure out the expression status, specific role and potential upstream mechanism of TLR4.Result: RT-qPCR identified that TLR4 expression was upregulated in ALI mice and LPS-induced WI-38 cells. Moreover, miR-26a-5p was confirmed to target TLR4 according to luciferase reporter assay. Besides, miR-26a-5p overexpression decreased the contents of proinflammatory factors (TNF-α and IL-1β) and restrained cell apoptosis, while upregulation of TLR4 reversed these effects of miR-26a-5p mimics, implying that miR-26a-5p alleviated ALI through regulating TLR4. Afterwards, OIP5-AS1 was identified to bind with miR-26a-5p by RNA immunoprecipitation (RIP) and luciferase reporter assay. Functionally, OIP5-AS1 upregulation accelerated the inflammation injuries and miR-26a-5p overexpression counteracted the influence of OIP5-AS1 upregulation on proinflammatory factors and cell apoptosis.Conclusion: OIP5-AS1 accelerated ALI through regulating miR-26a-5p/TLR4 axis in ALI mice and LPS-induced cells, which indicates a promising insight into diagnostics and therapeutics in ALI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.